Antonio Ferrer-Montiel

Articles in Scholarly Journals [Incomplete List]

  1. Old Molecules for New Receptors: Trp(Nps) Dipeptide Derivatives as Vanilloid TRPV1 Channel Blockers
    ChemMedChem, vol. 1, no. 4, pp. 429–438, 2006
  2. Design and Characterization of a Noncompetitive Antagonist of the Transient Receptor Potential Vanilloid Subunit 1 Channel With In Vivo Analgesic and Anti-inflammatory Activity
    The Journal of Pain, vol. 7, no. 10, pp. 735–746, 2006
  3. Small molecule inhibitors of Apaf-1-related caspase- 3/-9 activation that control mitochondrial-dependent apoptosis
    Cell Death and Differentiation, vol. 13, no. 9, Article ID 4401828, 9 pages, 2006
  4. Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival
    Journal of Cell Science, vol. 119, no. 5, pp. 898–909, 2006
  5. Effects of coffees before and after special treatment procedure on cell membrane potentials in stomach cells
    Methods and Findings in Experimental and Clinical Pharmacology, vol. 28, no. 6, p. 369, 2006
  6. Pharmacological Intervention at Ionotropic Glutamate Receptor Complexes
    Current Pharmaceutical Design, vol. 12, no. 28, pp. 3583–3596, 2006
  7. Physiology and Pharmacology of the Vanilloid Receptor
    Current Neuropharmacology, vol. 4, no. 1, pp. 1–15, 2006
  8. Design and synthesis of an optimized positional scanning library of peptoids: identification of novel multidrug resistance reversal agents
    Bioorganic & Medicinal Chemistry, vol. 13, no. 6, pp. 1923–1929, 2005
  9. Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia
    Pflügers Archiv - European Journal of Physiology, vol. 451, no. 1, pp. 151–159, 2005
  10. Acquisition of multidrug resistance by L1210 leukemia cells decreases their tumorigenicity and enhances their susceptibility to the host immune response
    Cancer Immunology, Immunotherapy, vol. 54, no. 4, pp. 328–336, 2004
  11. Design of bioactive and structurally well-defined peptides from conformationally restricted libraries
    Biopolymers, vol. 76, no. 4, pp. 357–365, 2004
  12. Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation
    FEBS Letters, vol. 578, no. 1-2, pp. 121–127, 2004
  13. Journal of Combinatorial Chemistry, vol. 6, no. 1, pp. 135–141, 2004
  14. Identification of a Tetramerization Domain in the C Terminus of the Vanilloid Receptor
    Journal of Neuroscience, vol. 24, no. 23, pp. 5307–5314, 2004
  15. Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity
    Journal of Biological Chemistry, vol. 279, no. 24, pp. 25665–25672, 2004
  16. Oligomerization of the Sensory and Motor Neuron-derived Factor Prevents Protein O-Glycosylation
    Journal of Biological Chemistry, vol. 279, no. 32, pp. 33623–33629, 2004
  17. Molecular Compatibility of the Channel Gate and the N Terminus of S5 Segment for Voltage-gated Channel Activity
    Journal of Biological Chemistry, vol. 280, no. 18, pp. 18253–18264, 2004
  18. Molecular architecture of the vanilloid receptor. Insights for drug design
    European Journal of Biochemistry, vol. 271, no. 10, pp. 1820–1826, 2004
  19. Trimers of N-Alkylglycines Are Potent Modulators of the Multidrug Resistance Phenotype
    Journal of Pharmacology and Experimental Therapeutics, vol. 313, no. 1, pp. 112–120, 2004
  20. GAP43 stimulates inositol trisphosphate-mediated calcium release in response to hypotonicity
    The EMBO Journal, vol. 22, no. 12, pp. 3004–3014, 2003
  21. Small Molecules Targeting the NMDA Receptor Complex as Drugs for Neuropathic Pain
    Mini Reviews in Medicinal Chemistry, vol. 3, no. 7, pp. 749–756, 2003
  22. Small molecules targeting the vanilloid receptor complex as drugs for inflammatory pain
    Drugs of the Future, vol. 28, no. 8, p. 787, 2003
  23. Identification of SNARE complex modulators that inhibit exocytosis from an a-helix-constrained combinatorial library
    Biochemical Journal, vol. 375, no. 1, p. 159, 2003
  24. TRV1 involvement in inflammatory pain: mechanisms and pharmacological modulation
    Journal of Neurochemistry, vol. 85, no. s2, pp. 4–4, 2003
  25. Attenuation of thermal nociception and hyperalgesia by VR1 blockers
    Proceedings of the National Academy of Sciences, vol. 99, no. 4, pp. 2374–2379, 2002
  26. A synthetic hexapeptide (Argireline) with antiwrinkle activity
    International Journal of Cosmetic Science, vol. 24, no. 5, pp. 303–310, 2002
  27. Biochemistry, vol. 41, no. 40, pp. 12263–12269, 2002
  28. Molecular Determinants of the Sensory and Motor Neuron-derived Factor Insertion into Plasma Membrane
    Journal of Biological Chemistry, vol. 277, no. 22, pp. 19905–19912, 2002
  29. Neuroprotection Against Excitotoxicity by N-Alkylglycines in Rat Hippocampal Neurons
    NeuroMolecular Medicine, vol. 2, no. 3, pp. 271–280, 2002
  30. Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
    Journal of Pharmacology and Experimental Therapeutics, vol. 301, no. 1, pp. 29–36, 2002
  31. A Novel N-Methyl-D-aspartate Receptor Open Channel Blocker with in Vivo Neuroprotectant Activity
    Journal of Pharmacology and Experimental Therapeutics, vol. 302, no. 1, pp. 163–173, 2002
  32. Structural Compatibility between the Putative Voltage Sensor of Voltage-gated K+ Channels and the Prokaryotic KcsA Channel
    Journal of Biological Chemistry, vol. 276, no. 24, pp. 21070–21076, 2001
  33. Biochemistry, vol. 40, no. 7, pp. 2234–2242, 2001
  34. Arginine-rich peptides are blockers of VR-1 channels with analgesic activity
    FEBS Letters, vol. 481, no. 2, pp. 131–136, 2000
  35. Erratum: Peptides that mimic the carboxy-terminal domain of SNAP-25 block acetylcholine release at anAplysia synapse.J Appl Toxicol 1999;19: S23-S26.
    Journal of Applied Toxicology, vol. 20, no. 6, pp. 499–499, 2000
  36. Identification of an Aspartic Residue in the P-loop of the Vanilloid Receptor That Modulates Pore Properties
    Journal of Biological Chemistry, vol. 275, no. 42, pp. 32552–32558, 2000
  37. Activation of Store-Operated Ca2+ Current in Xenopus Oocytes Requires SNAP-25 but Not a Diffusible Messenger
    Cell, vol. 98, no. 4, pp. 475–485, 1999
  38. Structural stabilization of botulinum neurotoxins by tyrosine phosphorylation
    FEBS Letters, vol. 429, no. 1, pp. 78–82, 1998
  39. The 26-mer peptide released from SNAP-25 cleavage by botulinum neurotoxin E inhibits vesicle docking
    FEBS Letters, vol. 435, no. 1, pp. 84–88, 1998
  40. Structural determinants of the blocker binding site in glutamate and NMDA receptor channels
    Neuropharmacology, vol. 37, no. 2, pp. 139–147, 1998
  41. Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death
    Nature Biotechnology, vol. 16, no. 3, Article ID nbt0398-286, 5 pages, 1998
  42. Channels: singularly good signalling devices
    Trends in Cell Biology, vol. 7, no. 7, pp. 297–297, 1997
  43. A Peptide That Mimics the C-terminal Sequence of SNAP-25 Inhibits Secretory Vesicle Docking in Chromaffin Cells
    Journal of Biological Chemistry, vol. 272, no. 5, pp. 2634–2639, 1997
  44. Pentameric subunit stoichiometry of a neuronal glutamate receptor
    Proceedings of the National Academy of Sciences, vol. 93, no. 7, pp. 2741–2744, 1996
  45. Tyrosine Phosphorylation Modulates the Activity of Clostridial Neurotoxins
    Journal of Biological Chemistry, vol. 271, no. 31, pp. 18322–18325, 1996
  46. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells
    FEBS Letters, vol. 398, no. 1, pp. 12–18, 1996
  47. A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca2+-dependent exocytosis in chromaffin cells
    FEBS Letters, vol. 372, no. 1, pp. 39–43, 1995
  48. Molecular Design of the N-Methyl-D-Aspartate Receptor Binding Site for Phencyclidine and Dizolcipine
    Proceedings of the National Academy of Sciences, vol. 92, no. 17, pp. 8021–8025, 1995
  49. Mutation of Conserved Negatively Charged Residues in the S2 and S3 Transmembrane Segments of a Mammalian K+ Channel Selectively Modulates Channel Gating
    Proceedings of the National Academy of Sciences, vol. 92, no. 20, pp. 9422–9426, 1995
  50. Structure-Function Relations in Ligand-Gated Ion Channels: Reconstitution in Lipid Bilayers and Heterologous Expression in Xenopus Oocytes
    Methods, vol. 6, no. 1, pp. 60–69, 1994
  51. Possible coexistence of two independent mechanisms contributing to anthracycline resistance in leukaemia P388 cells
    European Journal of Cancer, vol. 29, no. 15, pp. 2144–2150, 1993
  52. A negative charge in the M2 transmembrane segment of the neuronal a7 acetylcholine receptor increases permeability to divalent cations
    FEBS Letters, vol. 324, no. 2, pp. 185–190, 1993
  53. Molecular Cloning, Functional Expression, and Pharmacological Characterization of an N-Methyl-D-Aspartate Receptor Subunit from Human Brain
    Proceedings of the National Academy of Sciences, vol. 90, no. 11, pp. 5057–5061, 1993
  54. Primary Structure, Chromosomal Localization, and Functional Expression of a Voltage-Gated Sodium Channel from Human Brain
    Proceedings of the National Academy of Sciences, vol. 89, no. 17, pp. 8220–8224, 1992
  55. Molecular Cloning, Chromosomal Mapping, and Functional Expression of Human Brain Glutamate Receptors
    Proceedings of the National Academy of Sciences, vol. 89, no. 4, pp. 1443–1447, 1992
  56. Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388 leukemia cells
    Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1104, no. 1, pp. 111–116, 1992
  57. Agonist-Independent Activation of Acetylcholine Receptor Channels by Protein Kinase A Phosphorylation
    Proceedings of the National Academy of Sciences, vol. 88, no. 22, pp. 10213–10217, 1991
  58. Biochemistry, vol. 29, no. 31, pp. 7275–7282, 1990
  59. Ultrastructural alterations in plasma membranes from drug-resistant P388 murine leukemia cells
    Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1029, no. 1, pp. 191–195, 1990
  60. Association of daunomycin to membrane domains studied by fluorescence resonance energy transfer
    Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 937, pp. 379–386, 1988
  61. The Surface Charge of Membranes Modulates the Interaction with the Anthracycline Daunomycin
    Annals of the New York Academy of Sciences, vol. 551, no. 1 Membrane in C, pp. 443–445, 1988